Depression post-myocardial infarction [2]

British Journal of Psychiatry

Volumn 191, Issue NOV., 2007, Pages 455-456

  Shetty, A ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; DEPRESSION; HEART INFARCTION; HUMAN; LETTER; MEDICAL ETHICS; MEDICAL RESEARCH; MOOD DISORDER; NOTE; PROGNOSIS; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; RESEARCH ETHICS;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; TREATMENT OUTCOME; ETHICS, RESEARCH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 35948948648     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.191.5.455a     Document Type: Letter

References (2)

1. Torgerson, D. J. (2001) Contamination in trials: is cluster randomisation the answer? BMJ, 322, 355-357.
2. Zelen, M. (1979) A new design for randomized clinical trials. New England Journal of Medicine, 300, 1242-1245.